Good Wednesday Morning, Its September 21st, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. On its the Fourth Quarter fiscal 2011, Analogic Corporation - symbol ALOG - posted Revenues of $135.3 million, an 18% increase year over year Northern Oil and Gas Incorporated - symbol NOG - was upgraded by Brokerage Firm Global Hunter Securities from Accumulate to Buy and finally After meeting with the U.S. Food and Drug Administration, Orexigen Therapeutics Incorporated - symbol OREX - has decided to again pursue approval of its diet-drug Contrave. FDA will allow Orexigen to resubmit for approval if an interim analysis of the safety study comes back clean. According to the National Health and Examination Survey, about one-third of U.S. adults and approximately 17% of children and adolescents aged 2—19 years are obese. Thanks for joining me and have a great week! For CRWE Newswire, Stocks In Action, I’m Sara Bryant/n

Tags: ALOG, AMEX:NOG, Analogic, NASDAQ:ALOG, NASDAQ:OREX, NOG, Northern Oil and Gas, OREX, Orexigen Therapeutics